<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.

MD Biosciences

Promoting Diversity for Translational Success

In preclinical efficacy studies, several factors are often overlooked, and it is important to evaluate variables like sex, age, species,...

Read More

In Vitro Modeling

The goal of the preclinical development process is to help predict clinical efficacy, emphasizing the importance of studying diseases through models...

Read More

The HTX-011 Story

HTX-011 Breakthrough in Pain Management ZYNRELEF, the commercial name for HTX-011, is the first and only FDA-approved extended-release dual-acting...

Read More

Wound Healing Models in Pigs

It is important to bridge the gap between lab findings and clinical applications using translational models, ensuring effective translation for human...

Read More

Advancing Nerve Injury and Repair Models

Understanding Mechanisms Underlying Neuropathic Pain

Read More
Porcine translational research - advancing beyond rodents and non-human primates

Porcine Translational Research

Advancing Beyond Rodent and Non-Human Primate Models While rodent models have contributed significantly to our understanding of various diseases and...

Read More

Increase diversity to improve clinical translation and strengthen pain management outcomes.

The goal of preclinical drug development is to identify potential therapeutic compounds and gain an understanding of disease pathways or target...

Read More